Interleukin-1 receptor

Multi tool use
See also: Interleukin-1 receptor family
interleukin 1 receptor, type I |
Identifiers |
Symbol |
IL1R1 |
Alt. symbols |
IL1R, IL1RA |
Entrez |
3554 |
HUGO |
5993 |
OMIM |
147810 |
RefSeq |
NM_000877 |
UniProt |
P14778 |
Other data |
Locus |
Chr. 2 q12
|
interleukin 1 receptor, type II |
Identifiers |
Symbol |
IL1R2 |
Alt. symbols |
IL1RB |
Entrez |
7850 |
HUGO |
5994 |
OMIM |
147811 |
RefSeq |
NM_173343 |
UniProt |
P27930 |
Other data |
Locus |
Chr. 2 q12
|
interleukin 1 receptor accessory protein |
Identifiers |
Symbol |
IL1RAP |
Alt. symbols |
IL-1RAcP, IL1R3, C3orf13 |
Entrez |
3556 |
HUGO |
5995 |
OMIM |
602626 |
RefSeq |
NM_134470 |
UniProt |
Q9NPH3 |
Other data |
Locus |
Chr. 3 q28
|
Interleukin-1 receptor (IL-1R) is a cytokine receptor which binds interleukin 1.[1] Two forms of the receptor exist. The type I receptor is primarily responsible for transmitting the inflammatory effects of interleukin-1 (IL-1) while type II receptors may act as a suppressor of IL-1 activity by competing for IL-1 binding.[1] Also opposing the effects of IL-1 is the IL-1 receptor antagonist (IL-1RA).[2]
The IL-1 receptor accessory protein (IL1RAP) is a transmembrane protein that interacts with IL-1R and is required for IL-1 signal transduction.[3]
References
^ ab Kuno K, Matsushima K (1994). "The IL-1 receptor signaling pathway" (abstract page). J. Leukoc. Biol. 56 (5): 542–7. PMID 7964161..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}
^ Arend WP (1991). "Interleukin 1 receptor antagonist. A new member of the interleukin 1 family". J. Clin. Invest. 88 (5): 1445–51. doi:10.1172/JCI115453. PMC 295645. PMID 1834696.
^ Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU (March 1997). "The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)". J. Biol. Chem. 272 (12): 7727–31. doi:10.1074/jbc.272.12.7727. PMID 9065432.
External links
Receptors,+Interleukin-1 at the US National Library of Medicine Medical Subject Headings (MeSH)
Cytokine receptors
|
Chemokine receptor (GPCRs) |
CC |
CCR1 / CCRL1
- CCR2
- CCRL2
- CCR3
- CCR4
- CCR5
- CCR6
- CCR7
- CCR8
- CCR9
- CCR10
|
CXC |
IL-8
- CXCR3
- CXCR4
- CXCR5
- CXCR6
- CXCR7
|
Other |
|
|
TNF receptor |
1-10 |
TNFR1 (TNFRSF1A)
TNFR2 (TNFRSF1B)
LTBR (TNFRSF3)
CD134 (TNFRSF4)
CD40 (TNFRSF5)
Fas receptor (TNFRSF6)
DcR3 (TNFRSF6B)
CD27 (TNFRSF7)
CD30 (TNFRSF8)
CD137 (TNFRSF9)
|
11-20 |
DR4 (TNFRSF10A)
DR5 (TNFRSF10B)
DcR1 (TNFRSF10C)
DcR2 (TNFRSF10D)
RANK (TNFRSF11A)
Osteoprotegerin (TNFRSF11B)
TweakR (TNFRSF12A)
TACI (TNFRSF13B)
BAFFR (TNFRSF13C)
HVEM (TNFRSF14)
NGFR (TNFRSF16)
BCMA (TNFRSF17)
GITR (TNFRSF18)
TAJ/TROY (TNFRSF19)
|
21-27 |
DR6 (TNFRSF21)
DR3 (TNFRSF25)
EDA2R (TNFRSF27)
|
|
JAK-STAT |
Type I |
γ-chain |
Interleukin receptors
IL2R / IL2RA/IL2RB / IL15R
IL4R / IL13R / IL13RA1 / IL13RA2
IL7R / IL7RA
- IL9R
- IL21R
|
β-chain |
Interleukin receptors
IL3R / IL3RA
IL5R / IL5RA
- GM-CSF
|
gp130 |
Interleukin receptors
- IL6RA
11/IL11RA
27/IL27RA
- OSMR
- LIFR
- CNTFR
|
IL12RB1 |
Interleukin receptors
IL12R/IL12RB1/IL12RB2
- IL23R23
|
Other |
hormone receptor: GH
- prolactin
|
|
Type II |
Interleukin receptors
IL10R / IL10RA / IL10RB / IL22R / IL22RA1 / IL22RA2
IL20R / IL20RA / IL20RB
- IL28R
Interferon receptors
-α/β / IFNAR1/IFNAR2
-γ/IFNGR1 / IFNGR2
|
|
Ig superfamily |
- CSF1
- KIT
IL1
IL18R / IL18R1
|
IL 17 family |
IL17
- IL17RA
- IL17RB
- IL17RC
- IL17RD
- IL17RE
|
S/T |
|
Interleukin receptor modulators
|
IL-1 |
Agonists: Interleukin 1 (α, β)
- Mobenakin
- Pifonakin
Antagonists: AF-12198
- Anakinra
- IL-1RA
- Isunakinra
Antibodies: Canakinumab
- Gevokizumab
- Lutikizumab
Decoy receptors: Rilonacept (IL-1 Trap)
|
IL-2 |
Agonists: Adargileukin alfa
- Aldesleukin
- Celmoleukin
- Denileukin diftitox
- Interleukin 2
- Pegaldesleukin
- Teceleukin
- Tucotuzumab celmoleukin
Antibodies: Basiliximab
- Daclizumab (dacliximab)
- Inolimomab
|
IL-3 |
Agonists: Daniplestim
- Interleukin 3
- Leridistim
- Milodistim
- Muplestim
- Promegapoietin
|
IL-4 |
Agonists: Binetrakin
- Interleukin 4
- Interleukin 13
Antibodies: Dupilumab
- Pascolizumab
|
IL-5 |
Antibodies: Benralizumab
- Mepolizumab
- Reslizumab
Antisense oligonucleotides: TPI ASM8
|
IL-6 |
Agonists: Atexakin alfa
- Interleukin 6
Antibodies: ARGX-109
- Clazakizumab
- Elsilimomab
- mAb 1339
- Olokizumab
- Sarilumab
- Siltuximab
- Sirukumab
- Tocilizumab
|
IL-7 |
|
IL-8 |
- See CXCR1 (IL-8Rα) and CXCR2 (IL-8Rβ) here instead.
|
IL-9 |
|
IL-10 |
Agonists: Ilodecakin
- Interleukin 10 (CSIF)
|
IL-11 |
Agonists: Interleukin 11 (AGIF)
- Oprelvekin
|
IL-12 |
Agonists: Edodekin alfa
- Interleukin 12
Antibodies: Briakinumab
- Ustekinumab
|
IL-13 |
Agonists: Binetrakin
- Cintredekin besudotox
- Interleukin 4
- Interleukin 13
Antibodies: Anrukinzumab
- Lebrikizumab
- Tralokinumab
|
IL-15 |
Agonists: ALT-803
- Interleukin 15
|
IL-17 |
Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F)
Antibodies: Brodalumab
- Ixekizumab
- Perakizumab
- Remtolumab
- Secukinumab
- Vunakizumab
|
IL-18 |
Agonists: Iboctadekin
- Interleukin 18
- Interleukin 37
- Tadekinig
|
IL-20 |
Agonists: Interleukin 19
- Interleukin 20
- Interleukin 24
Antibodies: Fletikumab (against IL-20)
|
IL-21 |
Agonists: Denenicokin
- Interleukin 21
Antibodies: NNC0114-0005
- NNC0114-0006
|
IL-22 |
Antibodies: Fezakinumab (against IL-22)
|
IL-23 |
Agonists: Interleukin 23 (SGRF)
Antibodies: Brazikumab
- Briakinumab
- Guselkumab
- Tildrakizumab
- Ustekinumab
|
IL-27 |
Agonists: Interleukin 27 (interleukin 30)
|
IL-28 |
Agonists: Interferon λ4 (IFN-λ4)
Interleukin 28 (A (IFN-λ2), B (IFN-λ3))
- Interleukin-29 (IFN-λ1)
|
IL-31 |
|
IL1RL1 |
|
IL1RL2 |
Agonists: Interleukin 36 (α, β, γ)
- Interleukin 38
|
Others |
JAK |
|
Others |
- Interleukin 14 (taxilin alpha, HMW-BCGF)
Interleukin 16 (signals through CD4)
Interleukin 24 (signals through IL-22Rα1/IL-20Rβ heterodimer)
Interleukin 26 (signals through IL-20Rα/IL-10Rβ heterodimer)
- Interleukin 32
Interleukin 34 (signals through M-CSFR/CSF1R)
- Interleukin 35
Unsorted: Efavaleukin alfa
- Efineptakin alfa
|
|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Cytokine receptor modulators
|
EuEcU Qv,Ny,lQl,U1Bc85MPb,AhM,z 4RrU2w1UIE,qVO2bqTIW1d2D
Popular posts from this blog
Florida Star v. B. J. F. From Wikipedia, the free encyclopedia Jump to navigation Jump to search United States Supreme Court case Florida Star v. B. J. F. Supreme Court of the United States Argued March 21, 1989 Decided June 21, 1989 Full case name The Florida Star v. B. J. F. Citations 491 U.S. 524 ( more ) 109 S. Ct. 2603; 105 L. Ed. 2d 443; 1989 U.S. LEXIS 3120; 57 U.S.L.W. 4816; 16 Media L. Rep. 1801 Prior history The Florida Star v. B.J.F., 530 So.2d 286 (1988) Supreme Court of Florida; Florida Star v. B.J.F., 499 So.2d 883 (1986) Fla. Dist. Court of Appeals Holding Florida Stat. § 794.03 is unconstitutional to the extent it makes the truthful reporting of information that was a matter of public record unlawful, as it violates the First Amendment. Court membership Chief Justice William Rehnquist Associate Justices William J. Brennan Jr. · Byron White Thurgood Marshall · Harry Blac...
Danny Elfman From Wikipedia, the free encyclopedia Jump to navigation Jump to search Danny Elfman Elfman at the 2010 San Diego Comic-Con Born Daniel Robert Elfman ( 1953-05-29 ) May 29, 1953 (age 65) Los Angeles, California, U.S. Spouse(s) Bridget Fonda ( m. 2003) Children 1 Musical career Genres Rock [1] ska [2] new wave film music video game music Occupation(s) Composer, singer, songwriter, record producer Instruments Trombone guitar percussion vocals keyboards [3] Years active 1972–present Associated acts Oingo Boingo James Newton Howard Daniel Robert Elfman (born May 29, 1953) is an American composer, singer, songwriter, and record producer. Elfman first became known for being the lead singer and songwriter for the band Oingo Boingo from 1974 to 1995. He is well known for scoring films and television shows, particularly his frequent collabora...
The Sandy Post From Wikipedia, the free encyclopedia Jump to navigation Jump to search The Sandy Post Type Weekly Newspaper Format Tabloid Owner(s) Community Newspapers/Pamplin Media Group Publisher J. Mark Garber Editor Steve Brown Founded 1937 ( 1937 ) Headquarters Sandy, Oregon Circulation 3,800 Website www.pamplinmedia.com/sandy-post-home/ This article needs additional citations for verification . Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2010) (Learn how and when to remove this template message) The Sandy Post is a weekly newspaper, published in Sandy, Oregon, United States. The paper, founded in 1937, serves the communities of Sandy, Boring, the Villages at Mount Hood and the surrounding areas. The newspaper is owned by Community Newspapers/Pamplin Media Group, a company of ...